SCHEMBL4185875

SCHEMBL4185875

Cc1nc(C)c(S(=O)(=O)Nc2ccccc2CN[C@@H](C)CC2CCCC2)s1

nearest known ligand 0.41

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.41
KDM4E B2RXH2 1/20 0.41
MAPT P10636 2/20 0.34
MEN1 O00255 1/20 0.34
KMT2A Q03164 1/20 0.34
ALDH1A1 P00352 3/20 0.34
PI4KB Q9UBF8 4/20 0.34
SLC8A1 P32418 1/20 0.33
PI4KA P42356 1/20 0.33
LMNA P02545 3/20 0.33
POLB P06746 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
KEAP1 Q14145 1/20 0.33
BCL2 P10415 1/20 0.32
BCL2L1 Q07817 1/20 0.32
NPY5R Q15761 1/20 0.32
KIT P10721 1/20 0.32
PCK1 P35558 1/20 0.32
HSD11B1 P28845 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4200078 0.99 PKM (0.42) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4204307 0.99 PKM (0.42) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4197554 0.95 KDM4E (0.39) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4185944 0.92 PKM (0.46) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4190907 0.90 PKM (0.40) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL12050351 0.80 PKM (0.44) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL14344020 0.80 KDM4E (0.41) PKMKDM4EMEN1KMT2AALDH1A1
SCHEMBL12050344 0.79 KDM4E (0.55) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4197986 0.79 KDM4E (0.47) PKMKDM4EMAPTMEN1KMT2A
SCHEMBL4201910 0.79 CNR1 (0.41) PKMKDM4EMAPTMEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP claimed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US claimed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US claimed
EP-1879877-B1 ANTIMICROBIAL AGENTS RANBAXY LAB LTD (IN) 2013-01-02 EP disclosed
US-8076370-B2 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2011-12-13 US disclosed
US-20090215764-A1 Antimicrobial agents RANBAXY LABORATORIES LIMITED (IN) 2009-08-27 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090215764-A1 Antimicrobial agents TUFM, RPS17, HARS1 PKM 1855/4885KDM4E 3328/4885MAPT 2269/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.